
|Articles|October 1, 2004
Quality of life evaluated for patients with AMD
Nashville-Although outcomes data from the Submacular Surgery Trials are not yet available, quality-of-life information from the study will help investigators evaluate the effectiveness of various treatment options for age-related macular degeneration (AMD), said Paul Sternberg Jr., MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ophthalmic innovation by the decades: The 2000s
2
The Residency Report: Social media and the modern ophthalmologist
3
EyePoint Pharmaceuticals details phase 3 program evaluating vorolanib intravitreal insert (DURAVYU) for DME
4
AAO 2025: When and where to find all 18 named lectures
5